ARG
ABBV icon

Advisory Resource Group’s AbbVie ABBV Stock Holding History

Advisory Resource Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$286K Sell
1,136
-36
-3% -$7.75K 0.04% 164
2026
Q1 		$255K Sell
1,172
-919
-44% -$204K 0.04% 158
2025
Q4 		$478K Buy
2,091
+146
+8% +$33.3K 0.08% 128
2025
Q3 		$450K Buy
1,945
+17
+0.9% +$3.46K 0.08% 138
2025
Q2 		$358K Buy
1,928
+12
+0.6% +$2.23K 0.07% 140
2025
Q1 		$401K Buy
1,916
+12
+0.6% +$2.33K 0.08% 136
2024
Q4 		$338K Buy
1,904
+56
+3% +$10.3K 0.07% 136
2024
Q3 		$365K Sell
1,848
-39
-2% -$7.28K 0.08% 129
2024
Q2 		$324K Sell
1,887
-88
-4% -$14.6K 0.07% 128
2024
Q1 		$360K Buy
1,975
+11
+0.6% +$1.9K 0.08% 128
2023
Q4 		$304K Buy
1,964
+14
+0.7% +$2.04K 0.08% 131
2023
Q3 		$291K Sell
1,950
-223
-10% -$32.7K 0.08% 130
2023
Q2 		$293K Sell
2,173
-243
-10% -$35.6K 0.08% 128
2023
Q1 		$385K Buy
2,416
+49
+2% +$7.49K 0.11% 123
2022
Q4 		$383K Buy
2,367
+11
+0.5% +$1.69K 0.11% 120
2022
Q3 		$316K Buy
2,356
+12
+0.5% +$1.72K 0.1% 102
2022
Q2 		$359K Buy
2,344
+11
+0.5% +$1.68K 0.12% 90
2022
Q1 		$378K Buy
2,333
+11
+0.5% +$1.6K 0.12% 97
2021
Q4 		$318K Sell
2,322
-37
-2% -$4.37K 0.11% 106
2021
Q3 		$254K Buy
2,359
+10
+0.4% +$1.14K 0.09% 116
2021
Q2 		$265K Buy
2,349
+11
+0.5% +$1.24K 0.11% 111
2021
Q1 		$253K Buy
2,338
+11
+0.5% +$1.18K 0.12% 87
2020
Q4 		$249K Buy
2,327
+11
+0.5% +$1.06K 0.12% 84
2020
Q3 		$203K Buy
2,316
+34
+1% +$3.2K 0.12% 90
2020
Q2 		$224K Buy
+2,282
New +$201K 0.14% 77

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Advisory Resource Group's ABBV Position: Q2 2026 in Review

Advisory Resource Group reduced its AbbVie (ABBV) stake by 3.1% in Q2 2026, selling an estimated $7.75K and leaving 1,136 shares worth $286K. The position accounts for 0.04% of the portfolio, ranked #164.

Advisory Resource Group first reported a position in ABBV in Q2 2020 and has held it in 25 quarters since. The position peaked at $478K in Q4 2025. 4,189 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Advisory Resource Group held 1,136 shares of AbbVie worth $286K as of Q2 2026.
  • Advisory Resource Group sold 36 AbbVie shares in Q2 2026, an estimated $7.75K.
  • AbbVie made up 0.04% of Advisory Resource Group's portfolio in Q2 2026, its #164 holding.
  • Advisory Resource Group first reported a position in AbbVie in Q2 2020 and has held it in 25 quarters since.
  • Advisory Resource Group's AbbVie position peaked at $478K in Q4 2025.
  • 4,189 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Advisory Resource Group's 13F filing for Q2 2026, filed 14 Jul 2026.